148 related articles for article (PubMed ID: 23581641)
1. Bruton's tyrosine kinase: potential target in human multiple myeloma.
Liu Y; Dong Y; Jiang QL; Zhang B; Hu AM
Leuk Lymphoma; 2014 Jan; 55(1):177-81. PubMed ID: 23581641
[TBL] [Abstract][Full Text] [Related]
2. Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease.
Bam R; Ling W; Khan S; Pennisi A; Venkateshaiah SU; Li X; van Rhee F; Usmani S; Barlogie B; Shaughnessy J; Epstein J; Yaccoby S
Am J Hematol; 2013 Jun; 88(6):463-71. PubMed ID: 23456977
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases.
Li Z; Wahl MI; Eguinoa A; Stephens LR; Hawkins PT; Witte ON
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13820-5. PubMed ID: 9391111
[TBL] [Abstract][Full Text] [Related]
4. Role of Bruton's tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells.
Bam R; Venkateshaiah SU; Khan S; Ling W; Randal SS; Li X; Zhang Q; van Rhee F; Barlogie B; Epstein J; Yaccoby S
Blood Cancer J; 2014 Aug; 4(8):e234. PubMed ID: 25083818
[TBL] [Abstract][Full Text] [Related]
5. Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia.
Ritis K; Speletas M; Tsironidou V; Pardali E; Kanariou M; Moschese V; Orlandi P; Skordala M; Rossi P; Kartalis G; Bourikas G; Sideras P
Br J Haematol; 1998 Sep; 102(5):1241-8. PubMed ID: 9753052
[TBL] [Abstract][Full Text] [Related]
6. Dual functions of Bruton's tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis.
Jongstra-Bilen J; Puig Cano A; Hasija M; Xiao H; Smith CI; Cybulsky MI
J Immunol; 2008 Jul; 181(1):288-98. PubMed ID: 18566394
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Bruton's tyrosine kinase by c-Abl.
Bäckesjö CM; Vargas L; Superti-Furga G; Smith CI
Biochem Biophys Res Commun; 2002 Dec; 299(3):510-5. PubMed ID: 12445832
[TBL] [Abstract][Full Text] [Related]
8. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
9. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
10. Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev AO; Mao C; Uckun FM
Leuk Lymphoma; 2003 Jun; 44(6):1011-8. PubMed ID: 12854903
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I.
Sacristán C; Tussié-Luna MI; Logan SM; Roy AL
J Biol Chem; 2004 Feb; 279(8):7147-58. PubMed ID: 14623887
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization and function analysis of grouper (Epinephelus coioides) Bruton's tyrosine kinase BTK.
Mo ZQ; Han Q; Zeng YL; Wang JL; Li XZ; Li YW; Sun HY; Li AX; Luo XC; Dan XM
Fish Shellfish Immunol; 2018 Jun; 77():91-99. PubMed ID: 29567142
[TBL] [Abstract][Full Text] [Related]
13. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.
Yang W; Desiderio S
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):604-9. PubMed ID: 9012831
[TBL] [Abstract][Full Text] [Related]
14. Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.
Von Suskil M; Sultana KN; Elbezanti WO; Al-Odat OS; Chitren R; Tiwari AK; Challagundla KB; Srivastava SK; Jonnalagadda SC; Budak-Alpdogan T; Pandey MK
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071917
[TBL] [Abstract][Full Text] [Related]
15. Silencing of Bruton's tyrosine kinase (Btk) using short interfering RNA duplexes (siRNA).
Heinonen JE; Smith CI; Nore BF
FEBS Lett; 2002 Sep; 527(1-3):274-8. PubMed ID: 12220673
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
17. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.
Smith CI; Baskin B; Humire-Greiff P; Zhou JN; Olsson PG; Maniar HS; Kjellén P; Lambris JD; Christensson B; Hammarström L
J Immunol; 1994 Jan; 152(2):557-65. PubMed ID: 8283037
[TBL] [Abstract][Full Text] [Related]
18. Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains.
Oeltjen JC; Malley TM; Muzny DM; Miller W; Gibbs RA; Belmont JW
Genome Res; 1997 Apr; 7(4):315-29. PubMed ID: 9110171
[TBL] [Abstract][Full Text] [Related]
19. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families.
Guo S; Wahl MI; Witte ON
Int Immunol; 2006 Jan; 18(1):79-87. PubMed ID: 16291652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
